Madrigal Pharmaceuticals's market cap is currently $7.41B. The company's EPS TTM is $-25.073; its P/E ratio is ―; Madrigal Pharmaceuticals is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-3.92. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -527.00K	$ -467.00K	$ -405.00K	$ -471.00K	$ -112.00K
Operating Income	$ -380.50M	$ -293.57M	$ -242.48M	$ -206.67M	$ -94.97M
EBITDA	$ -379.97M	$ -293.10M	$ -242.08M	$ -206.20M	$ -94.86M
Net Income	$ -373.63M	$ -299.31M	$ -241.08M	$ -197.44M	$ -72.81M
Balance Sheet
Cash & Short-Term Investments	$ 634.13M	$ 358.77M	$ 270.35M	$ 284.15M	$ 439.05M
Total Assets	$ 640.55M	$ 362.57M	$ 273.33M	$ 287.00M	$ 442.06M
Total Debt	$ 117.19M	$ 49.89M	$ 797.00K	$ 786.00K	$ 676.00K
Net Debt	$ 17.28M	$ -281.66M	$ -35.47M	$ -53.22M	$ -46.02M
Total Liabilities	$ 235.21M	$ 165.18M	$ 77.22M	$ 47.02M	$ 25.49M
Stockholders' Equity	$ 405.33M	$ 197.39M	$ 196.11M	$ 239.97M	$ 416.56M
Cash Flow
Free Cash Flow	$ -325.71M	$ -225.07M	$ -184.13M	$ -157.90M	$ -41.80M
Operating Cash Flow	$ -324.23M	$ -224.86M	$ -183.92M	$ -157.56M	$ -41.62M
Investing Cash Flow	$ -502.52M	$ 206.69M	$ -5.05M	$ 159.78M	$ 30.71M
Financing Cash Flow	$ 595.12M	$ 313.45M	$ 171.24M	$ 5.09M	$ 235.00K

Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History

Income Statement >

Madrigal Pharmaceuticals Debt to Assets

Balance Sheet >

Madrigal Pharmaceuticals Cash Flow

Cash Flow >

Madrigal Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing